scispace - formally typeset
Journal ArticleDOI

Cannabinoids in treatment-resistant epilepsy: A review.

Brooke K. O'Connell, +2 more
- 01 May 2017 - 
- Vol. 70, Iss: 70, pp 341-348
TLDR
Open-label studies with 100mg/ml CBD have provided additional evidence of its efficacy along with an adequate safety profile in children and young adults with a spectrum of TREs and Phase 3 RCTs with Epidiolex support efficacy and adequate safety profiles for children with DS and LGS.
About
This article is published in Epilepsy & Behavior.The article was published on 2017-05-01. It has received 162 citations till now. The article focuses on the topics: Cannabis & Cannabidiol.

read more

Citations
More filters
Journal ArticleDOI

Evidence for cannabis and cannabinoids for epilepsy: a systematic review of controlled and observational evidence

TL;DR: Drug-grade CBD as adjuvant treatment in paediatric-onset drug-resistant epilepsy may reduce seizure frequency and quality of life; RCTs examining other syndromes and cannabinoids are needed.
Journal ArticleDOI

Medicinal Cannabis for Psychiatric Disorders: A Clinically-Focused Systematic Review

TL;DR: There is currently encouraging, albeit embryonic, evidence for medicinal cannabis in the treatment of a range of psychiatric disorders, however, clinicians need to be mindful of arange of prescriptive and occupational safety considerations, especially if initiating higher dose THC formulas.
Journal ArticleDOI

Use of Cannabidiol in the Treatment of Epilepsy: Efficacy and Security in Clinical Trials.

TL;DR: Evaluated the use of CBD, in addition to common anti-epileptic drugs, in the severe treatment-resistant epilepsy through an overview of recent literature and clinical trials aimed to study the effects of the CBD treatment in different forms of epilepsy.
Journal ArticleDOI

Unique treatment potential of cannabidiol for the prevention of relapse to drug use: preclinical proof of principle

TL;DR: Proof of principle supporting potential of CBD in relapse prevention along two dimensions is provided: beneficial actions across several vulnerability states and long-lasting effects with only brief treatment.
Journal ArticleDOI

Quality of Life in Childhood Epilepsy in pediatric patients enrolled in a prospective, open-label clinical study with cannabidiol.

TL;DR: The results suggest that CBD may have beneficial effects on patient QOL, distinct from its seizure‐reducing effects; however, further studies in placebo‐controlled, double‐blind trials are necessary to confirm this finding.
References
More filters
Journal ArticleDOI

Early Identification of Refractory Epilepsy

TL;DR: Patients who have many seizures before therapy or who have an inadequate response to initial treatment with antiepileptic drugs are likely to have refractory epilepsy.
Journal ArticleDOI

Adverse Health Effects of Marijuana Use

TL;DR: As marijuana use becomes legal in some states, the dominant public opinion is that marijuana is a harmless source of mood alteration, but enough information is available to cause concern.
Related Papers (5)